Eqis Capital Management, Inc. Albemarle Corp Transaction History

Eqis Capital Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$108.73 - $146.89 $64,150 - $86,665	-590 Reduced 27.87%	1,527 $201,000
Q4 2023 Feb 14, 2024	BUY	$113.26 - $170.8 $9,740 - $14,688	86 Added 4.23%	2,117 $305,000
Q3 2023 Nov 13, 2023	SELL	$162.63 - $243.44 $60,010 - $89,829	-369 Reduced 15.38%	2,031 $345,000
Q2 2023 Aug 14, 2023	SELL	$172.91 - $232.22 $49,798 - $66,879	-288 Reduced 10.71%	2,400 $535,000
Q1 2023 May 15, 2023	SELL	$208.49 - $290.15 $30,231 - $42,071	-145 Reduced 5.12%	2,688 $594,000
Q4 2022 Feb 14, 2023	BUY	$214.02 - $325.38 $606,318 - $921,801	2,833 New	2,833 $614,000
Q2 2018 Jul 27, 2018	SELL	$88.96 - $104.92 $565,429 - $666,871	-6,356 Closed	0 $0
Q1 2018 Apr 06, 2018	BUY	$89.56 - $137.45 $985 - $1,511	11 Added 0.17%	6,356 $590,000
Q4 2017 Jan 25, 2018	SELL	$127.48 - $144.58 $7,903 - $8,963	-62 Reduced 0.97%	6,345 $811,000
Q3 2017 Oct 03, 2017	BUY	$109.36 - $136.31 $700,669 - $873,338	6,407	6,407 $873,000

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.